Research for the Improvement in Measurement Methods and the Effect of Sodium Intake on Cardiovascular Health
NCT ID: NCT01438619
Last Updated: 2013-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
620 participants
OBSERVATIONAL
2011-04-30
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present survey study was designed 1) to test the feasibility of 24 hour urinary sodium measurement for the estimation of sodium intake (including percentage of complete 24 hour urine sample collection) in the population based study; 2) to establish feasible method of 24 hour urinary sodium measurement; 3) to compare 24 hour urinary sodium measurement to the dietary survey method; and 4) to estimate the sodium intake by 24 hour urinary sodium measurement in Goyang city general population (aged 20-70 years).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increased Salt Intake in Healthy Men
NCT02509962
Randomized Study on Salt Intake and Energy Metabolism
NCT03024567
'Low-salt' Bread as a Means of Reducing Dietary Salt and Lowering Blood Pressure
NCT04003597
Salt Sources Study
NCT02474693
The Salty Gut: Effects of High Dietary Salt Intake on the Gut Microbiota
NCT04229680
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. 24 hour urine Na, K and Creatinine, 24 hour urine amount
1. Calculation of urine completeness index : Creatinine/(21 x Bwt)
2. Definition of incomplete urine collection: complete index less than 0.7 and loss of urine more than one time or 100 mL
2. 24 hour ambulatory blood pressure
1. mobile-O-graph (IEM GmbH)
2. measurement interval: 30 minutes
3. Measurement of peripheral blood pressure : microlife WatchBP office
1. Sitting position
2. After 5 minutes resting
3. Peripheral systolic BP (pSBP), Peripheral diastolic BP (pDBP),
4. Central aortic blood pressure
1. SphygmoCor (AtCor Medical, Australia)
2. Central systolic blood pressure
5. Pulse wave velocity
1. VP2000 (Colin, Japan)
2. pulse wave velocity (PWV): carotid-femoral Pulse Wave Velocity, heart-femoral Pulse Wave Velocity and brachial-ankle Pulse Wave Velocity
3. distance measured by tape: distance from suprasternal notch to carotid artery, distance from suprasternal notch to femoral artery
4. Silent environment
6. Electrocardiography
7. Blood chemistry and complete blood count
1. Measure at the morning of first day after overnight fasting
2. complete blood count, blood urea nitrogen/Creatinine, Fasting blood glucose, Total cholesterol, triglyceride, HDL cholesterol
Measurement protocol
1. 1st day
1. Visit hospital before 9:00 AM after overnight fasting
2. Sampling of venous blood
3. start 24 hour urine collection from 9:00 AM (with education for complete collection)
4. start 24 hour ambulatory blood pressure monitoring, in parallel with 24 hour urine collection
2. 2nd day
1. Measure central aortic blood pressure
2. Measure Pulse Wave Velocity
3. Electrocardiography
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
representitives of Goyang city
1. Representative population of Goyang city who were randomly selected by digit dialing (RDD) method
2. Volunteers who are reside in Goyang city
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known chronic kidney disease
* Unable to measure 24 hour ambulatory blood pressure measurement
* Unable to collect 24 hour urine sample
* Pregnancy
* Alcoholics
* Severe liver disease
* Night workers
* Mental retardation
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Food and Drug Safety, Korea
OTHER_GOV
DongGuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moo-Yong Rhee
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Moo-Yong Rhee, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Clinical Trial Center, Dongguk University Ilsan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Trial Center, Dongguk University Ilsan Hospital
Goyang-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11162KFDA162
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
11162KFDA162
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.